Repligen | RGEN - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Agilent USD 2.29B 20M 2026-06
Align Technology USD 1.91B 4.9M 2026-09
Bio Techne USD 361.27M 197.57M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Bruker USD 1.17B 32.6M 2026-09
Charles River Laboratories USD 1.09B 45.49M 2026-09
Danaher USD 9.05B 945M 2026-09
Dentsply International USD 1.22B 32M 2026-09
General Electric Aerospace USD 42.4B 1.96B 2026-09
Henry Schein USD 3.6B 110M 2026-09
Illumina USD 1.16B 422M 2026-09
IQVIA Holdings USD 7.78B 1.04B 2026-09
Mettler Toledo International USD 1.25B 49.81M 2026-09
Myriad Genetics USD 130.7M 500K 2026-06
OraSure Technologies USD 25.12M 18.96M 2026-06
Pacific Biosciences Of California USD 66.59M 2.21M 2026-09
Pfizer USD 31.73B 920M 2026-09
Repligen USD 125.69M 6.97M 2026-09
Revvity USD 701.48M 574.88M 2026-09
Standard Biotools USD 51.02M 5.78M 2026-09
Thermo Fisher Scientific USD 14.17B 899M 2026-09
Waters USD 2.4B 126M 2026-06
West Pharmaceutical Services USD 644.3M 3.8M 2026-09